January 22nd 2025, 10:00pm
By Eileen Kennedy
I've learned that cooking for friends during their cancer journey is a way to express love and support, even if it doesn't cure them.
January 22nd 2025, 9:37pm
By Julie Huynh-Lu, P.A.
A panelist discusses how patients should communicate comprehensively with their care team about symptom patterns, documentation methods, and warning signs of polycythemia vera progression, including key questions to ask themselves about symptom changes and recommended tracking tools.
January 22nd 2025, 8:00pm
By Alex Biese
CURE® spoke with experts about what life is like for patients with cancer when their disease is in remission.
January 22nd 2025, 6:00pm
By Ronald Chin
I rediscovered myself through community, writing, music and cooking after my journey with multiple myeloma.
January 22nd 2025, 4:00pm
By Ryan Scott
Dr. Christopher Flowers discusses MRD testing in cancer care, why this is an important concept to understand and how it relates to recurrence in patients.
January 22nd 2025, 3:00pm
By Dr. David A. Braun
Dr. David A Braun delved into detail on the molecular factors driving exceptional responses to immunotherapy in metastatic clear cell renal cell carcinoma.
January 22nd 2025, 2:00pm
Yescarta continued to demonstrate durable responses after a median follow-up of more than five years in patients with R/R indolent non-Hodgkin lymphoma.
January 21st 2025, 10:00pm
By Jill Feldman
The Lung Cancer Genetics Study, a collaboration between lung cancer advocacy organizations, aims to explore the genetics of lung cancer
January 21st 2025, 8:00pm
Patients with lymphoma or leukemia with methotrexate-induced acute kidney injury experienced improved renal outcomes following glucarpidase treatment.
January 21st 2025, 6:00pm
By Brian Sluga
My New Year's resolutions have evolved from seeking external goals to embracing personal growth and appreciating each day.
January 21st 2025, 4:00pm
An expert spoke with CURE about providers’ “two-fold goal” when using chemotherapy to treat patients with breast cancer.
January 21st 2025, 2:00pm
By Spencer Feldman
Missing weekly cisplatin cycles was associated with worse OS in patients with head and neck cancers, particularly for those with p16-negative tumors.
January 20th 2025, 10:00pm
A phase 2a trial of IMM-1-104 plus chemotherapy demonstrated efficacy and tolerability in first- and second-line pancreatic cancer.
January 20th 2025, 8:00pm
An expert spoke with CURE® about the emotional bonds that can develop while treating patients with cancer.
January 20th 2025, 6:00pm
By Karen Cohn
Waiting for results of a CT scan after a cancer diagnosis is agonizing, as I anxiously await news on whether my disease has returned.
A Close Companion Throughout my Cancer Journey
Could Cancer Vaccines Become a Reality Within the Next Decade?
Breaking Down the Treatment of GIST for Patients
How My Daughter’s Cancer Team Helped Me Stay Her Mom